Valtronic has more than 40 years of experience in the development and manufacture of innovative medical and diagnostic devices, including active implants.
As a result of the transaction, the Cicor Group will grow by around 220 employees and generate additional revenue of at least CHF 20 million. With the site in Cleveland, the Cicor Group is now present in the United States for the first time and can enter the market quickly and cost-effectively without the need to invest in a new facility. In Morocco, the acquisition of Valtronic’s site in Berrechid will double Cicor Group’s production capacity. The transfer of the two sites is expected to be completed in the next few weeks.
A CMS team led by Stefan Brunnschweiler (Partner) and Samuel Gang (Senior Associate, Corporate/M&A) provided comprehensive legal advice to the Cicor Group on this transaction. The Swiss team included Anna Mast (Senior Associate, Corporate/M&A), Miryam Meile (Senior Associate, Employment), Raphael Hammer (Junior Associate, Employment), Dominique Gemperli (Counsel, Finance), Maximilian Hauser (Associate, Finance), Helena Loretan (Senior Associate, Real Estate), Dirk Spacek (Partner, IP), Olivia Zingg (Associate, IP), as well as Mark Cagienard (Partner) and Jonas Weber (Associate, both Tax).
The Swiss team was supported by CMS Morocco, in particular Johan Bruneau (Associate, M&A) and Rachida Charifi (Head of Corporate).
